Research view
Switch to patient viewColorectal cancer: trials that stopped early
Trials on Colorectal cancer that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
254 stopped trials give a reason in the registry, latest registry update first. 4 more give no reason and are not listed.
Withdrawn
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer
Reason given in the registry “Prospective recruitment not possible”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Jul 2022.
- Phase
- Phase 3
- Run by
- Health Clinics Limited
- Registry record
- NCT02201381
Suspended
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
Reason given in the registry “DSMB stopped this trial due to the difference of 3-year DFS's rate between two groups more than 5% at the interim analysis in July 2021.”
Quoted unchanged from ClinicalTrials.gov; record updated 11 May 2022.
- Ended
- Feb 2026
- Phase
- Phase 3
- Run by
- Zhejiang University
- Registry record
- NCT02121405
Withdrawn
Calm for Cancer Patients Receiving Chemotherapy
Reason given in the registry “Study was never submitted to the IRB so never received permission to or enrolled any subjects”
Quoted unchanged from ClinicalTrials.gov; record updated 31 Mar 2022.
- Ended
- Dec 2023
- Run by
- The University of Texas Health Science Center at San Antonio
- Registry record
- NCT04345952
Withdrawn
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer
Reason given in the registry “implementation issues”
Quoted unchanged from ClinicalTrials.gov; record updated 8 Feb 2022.
- Ended
- Feb 2024
- Phase
- Phase 2
- Run by
- Roswell Park Cancer Institute
- Registry record
- NCT04119830
Withdrawn
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
Reason given in the registry “lack of resources”
Quoted unchanged from ClinicalTrials.gov; record updated 10 Nov 2021.
- Ended
- May 2025
- Phase
- Phase 2
- Run by
- UNC Lineberger Comprehensive Cancer Center
- Registry record
- NCT04418895
Withdrawn
Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Reason given in the registry “No approval from ethical committee”
Quoted unchanged from ClinicalTrials.gov; record updated 28 Sept 2021.
- Ended
- Oct 2024
- Phase
- Phase 2
- Run by
- Shanghai Minimally Invasive Surgery Center
- Registry record
- NCT04620473
Withdrawn
Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Reason given in the registry “No research funds were raised”
Quoted unchanged from ClinicalTrials.gov; record updated 10 Sept 2021.
- Ended
- Dec 2025
- Run by
- Ruijin Hospital
- Registry record
- NCT03633539
Withdrawn
Irreversible Electroporation of Unresectable Liver Tumors
Reason given in the registry “Low accrual rate”
Quoted unchanged from ClinicalTrials.gov; record updated 26 Mar 2021.
- Ended
- Mar 2025
- Run by
- Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
- Registry record
- NCT04404647
Withdrawn
Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC
Reason given in the registry “Study withdrawn prior to enrollment due to changing standard of care landscape.”
Quoted unchanged from ClinicalTrials.gov; record updated 21 Sept 2020.
- Ended
- Mar 2024
- Phase
- Phase 2
- Run by
- MedImmune LLC
- Registry record
- NCT04145193
Withdrawn
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
Reason given in the registry “No funding was raised”
Quoted unchanged from ClinicalTrials.gov; record updated 17 Feb 2020.
- Ended
- Mar 2026
- Run by
- Ruijin Hospital
- Registry record
- NCT03413930
Withdrawn
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
Reason given in the registry “No patient enrolled during the authorized period”
Quoted unchanged from ClinicalTrials.gov; record updated 30 Jan 2020.
- Ended
- Feb 2026
- Phase
- Phase 2
- Run by
- Institut de Cancérologie de la Loire
- Registry record
- NCT03323424
Withdrawn
Sym004 Versus TAS-102 in Patients With mCRC
Reason given in the registry “Study was withdrawn due to administrative reasons”
Quoted unchanged from ClinicalTrials.gov; record updated 4 Feb 2019.
- Ended
- Dec 2025
- Phase
- Phase 3
- Run by
- Symphogen A/S
- Registry record
- NCT03717038
Withdrawn
Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer
Reason given in the registry “Negative results in a similar study”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Oct 2018.
- Ended
- Feb 2025
- Phase
- Phase 2
- Run by
- Niharika Mettu
- Registry record
- NCT03340558
Withdrawn
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Reason given in the registry “Change in research focus”
Quoted unchanged from ClinicalTrials.gov; record updated 28 May 2012.
- Run by
- Stanford University
- Registry record
- NCT01031056
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.